Log In
BCIQ
Print this Print this
 

ALXN1210

  Manage Alerts
Collapse Summary General Information
Company Alexion Pharmaceuticals Inc.
DescriptionLong-acting humanized mAb against complement 5 (C5)
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today